EGA Becomes Medicines for Europe
March 10, 2016.
The European Generic and Biosimilar Medicines Association (EGA) has changed its name to Medicines for Europe. In a press release issued today, Medicines for Europe President Jacek Glinka explained that the repositioning "reflects our industries’ purpose and strategic objectives ... [W]e have been through an incredible journey responding to the changes that have taken place in the pharmaceutical industry and European healthcare environment. I invite stakeholders and policy-makers to engage with us to deliver access to high quality medicines for all European patients.” http://www.medicinesforeurope.com/
Is Artificial Intelligence a ‘Product’? Products Liability Implications for AI-Based Products
April 10th 2025As the physical products we use evolve to become increasingly complex, traditional products liability frameworks may not always fit to provide remedies for harm that can result from using novel product types.
